Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa

BACKGROUND: In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can characterise the scale and determinants of the pandemic, as well as elucidate protection conferred by prior exposure. METHODS: We conducted repeated cross-sectional serosurveys (July 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussey, Hannah, Vreede, Helena, Davies, Mary-Ann, Heekes, Alexa, Kalk, Emma, Hardie, Diana, van Zyl, Gert, Naidoo, Michelle, Morden, Erna, Bam, Jamy-Lee, Zinyakatira, Nesbert, Centner, Chad M, Maritz, Jean, Opie, Jessica, Chapanduka, Zivanai, Mahomed, Hassan, Smith, Mariette, Cois, Annibale, Pienaar, David, Redd, Andrew D., Preiser, Wolfgang, Wilkinson, Robert, Chetty, Kamy, Boulle, Andrew, Hsiao, Nei-yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753787/
https://www.ncbi.nlm.nih.gov/pubmed/36523408
http://dx.doi.org/10.1101/2022.12.01.22282927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753787/
https://www.ncbi.nlm.nih.gov/pubmed/36523408
http://dx.doi.org/10.1101/2022.12.01.22282927

Ejemplares similares